Detalhe da pesquisa
1.
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Hematol Oncol
; 41(5): 904-911, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452579